An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-16-0096
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Antitumor Activity of an Oncolytic Adenovirus-Delivered Oncogene Small Interfering RNA

Cancer Research
Cancer ResearchOncology
2006English

An Oncolytic Adenovirus That Expresses the HAb18 and Interleukin 24 Genes Exhibits Enhanced Antitumor Activity in Hepatocellular Carcinoma Cells

Oncotarget
Oncology
2016English

61PArming Oncolytic Adenovirus With FAP-targeting Bispecific T-Cell Engager to Improve Antitumor Efficacy

Annals of Oncology
MedicineOncologyHematology
2017English

Therapeutic Efficacy of an hTERT Promoter-Driven Oncolytic Adenovirus That Expresses Apoptin in Gastric Carcinoma

International Journal of Molecular Medicine
MedicineGenetics
2012English

The Oncolytic Adenovirus Targeting to TERT and RB Pathway Induced Specific and Potent Anti-Tumor Efficacy in Vitro and in Vivo for Hepatocellular Carcinoma

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2007English

Dual Promoter-Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models

Clinical Cancer Research
Cancer ResearchOncology
2005English

Efficacy of a New Oncolytic Adenovirus Armed With IL-13 Against Oral Carcinoma Models

OncoTargets and Therapy
OncologyPharmacology
2019English

Antitumor Effects of Oncolytic Adenovirus-Carrying siRNA Targeting Potential Oncogene EphA3

PLoS ONE
Multidisciplinary
2015English

Oncolytic Adenovirus Loaded With L-Carnosine as Novel Strategy to Enhance the Antitumor Activity

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy